AEONAEON Biopharma, Inc.

NYSE aeonbiopharma.com


$ 1.55 $ -0.08 (-4.91 %)    

Wednesday, 15-May-2024 15:06:17 EDT
QQQ $ 452.78 $ 3.86 (0.86 %)
DIA $ 398.76 $ 0.88 (0.22 %)
SPY $ 529.18 $ 3.26 (0.62 %)
TLT $ 92.02 $ 0.18 (0.2 %)
GLD $ 220.79 $ 1.55 (0.71 %)
$ 1.63
$ 1.53
$ 0.00 x 0
$ 0.00 x 0
$ 1.46 - $ 1.62
$ 1.38 - $ 17.17
46,281
na
60.75M
$ 0.42
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-29-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 07-21-2023 06-30-2023 10-Q
5 05-17-2023 03-31-2023 10-Q
6 02-22-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-28-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 06-15-2021 03-31-2021 10-Q
14 03-31-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-aeon-biopharma-lowers-price-target-to-6

HC Wainwright & Co. analyst Douglas Tsao maintains AEON Biopharma (AMEX:AEON) with a Buy and lowers the price target fro...

 aeon-biopharma-q1-2024-adj-eps-317-misses-031-estimate

AEON Biopharma (AMEX:AEON) reported quarterly losses of $(3.17) per share which missed the analyst consensus estimate of $(0.31...

 hc-wainwright--co-reiterates-buy-on-aeon-biopharma-maintains-18-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates AEON Biopharma (AMEX:AEON) with a Buy and maintains $18 price target.

 newly-listed-migraine-focused-aeon-biopharma-stock-plunges-on-friday---read-here-why

Preliminary results of AEON Biopharma's Phase 2 trial for chronic migraine treatment reveal no significant improvement over...

 hc-wainwright--co-reiterates-buy-on-aeon-biopharma-maintains-18-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates AEON Biopharma (AMEX:AEON) with a Buy and maintains $18 price target.

 gold-gains-1-cxapp-shares-spike-higher

U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.3% on Monday. The Dow traded down 0....

 why-nuvve-holding-shares-are-trading-lower-by-around-30-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expect...

 crude-oil-moves-higher-oxford-industries-shares-fall-after-q4-results

U.S. stocks traded lower midway through trading, with the Dow Jones falling over 300 points on Monday. The Dow traded down 0.7...

 dow-falls-over-200-points-ism-manufacturing-pmi-rises-in-march

U.S. stocks traded mixed this morning, with the Dow Jones falling over 200 points on Monday. The Dow traded down 0.57% to 39,5...

 aeon-biopharma-q4-eps-071
AEON Biopharma Q4 EPS $(0.71)
04/01/2024 13:39:53

AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.71) per share.

 aeon-biopharma-announces-15m-financing-transaction-and-termination-of-forward-purchase-agreements

-- Termination of the Forward Purchase Agreements simplifies AEON's capitalization structure -- -- AEON to expand its Board...

 aeon-biopharma-announces-clinical-update-and-productive-end-of-phase-2-meeting-with-fda-on-abp-450-for-preventive-treatment-of-migraine

– FDA and AEON align on the design and endpoints for the proposed pivotal Phase 3 trials for the preventive treatment of both e...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION